Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.78M 83.13M 74.23M 113.08M
Short-Term Investments
23.26M n/a 6.99M n/a
Long-Term Investments
n/a n/a 303K 302K
Other Long-Term Assets
2.47M 2.25M 3.08M 3.19M
Receivables
13.78M 16.99M 9.73M 9.44M
Inventory
24.32M 17.88M 14.49M 9.01M
Other Current Assets
3.59M 3.79M 6.76M 9.28M
Total Current Assets
76.73M 121.79M 112.2M 140.81M
Property-Plant & Equipment
12.98M 20.66M 22.45M 7.49M
Goodwill & Intangibles
32.82M 35.67M 38.31M 39.41M
Total Long-Term Assets
48.27M 58.58M 63.83M 50.09M
Total Assets
125M 180.37M 176.03M 190.91M
Account Payables
8.76M 11.78M 10.63M 9.44M
Deferred Revenue
6.55M 6.69M 6.28M 4.48M
Short-Term Debt
3.28M n/a 3.63M 272K
Other Current Liabilities
6.43M 6.36M 4.6M 6.72M
Total Current Liabilities
29.44M 35.34M 37.05M 27.68M
Long-Term Debt
76.18M 75.25M 63.28M 32.47M
Other Long-Term Liabilities
3.91M 5.76M 6.04M 7.85M
Total Long-Term Liabilities
87.97M 91.25M 80.39M 41.87M
Total Liabilities
117.41M 126.6M 117.45M 69.56M
Total Debt
84.15M 85.71M 75.78M 32.47M
Common Stock
2K 2K 2K 2K
Retained Earnings
-285.44M -230.07M -166.75M -96.11M
Comprehensive Income
7K n/a -6K -190.91M
Shareholders Equity
7.59M 53.77M 58.58M 121.35M
Total Investments
23.26M 699K 6.99M 302K